Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac
<p dir="ltr">Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac. A, B) The top significantly down (A) and up (B) regulated GO pathways in AD-MSC in comparison with PSCs treated with Muc5ac-proficient (KCT3266) or deficient (KCT3266 Muc5ac KO) CM. C, D) T...
Enregistré dans:
| Auteur principal: | Sushil Kumar (20371917) (author) |
|---|---|
| Publié: |
2025
|
| Sujets: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Supplementary Figure 1: Activation of AD-MSCs and PSCs by Muc5ac
par: Sushil Kumar (20371917)
Publié: (2025) -
Supplementary Figure 4: RNA-sequencing in the primary AD-MSCs, BM-MSCs, and PSCs after treatment with KC and KCM serum
par: Sushil Kumar (20371917)
Publié: (2025) -
Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
par: Sushil Kumar (20371917)
Publié: (2025) -
Supplementary Figure 6: Age-dependent differences in CAF activation
par: Sushil Kumar (20371917)
Publié: (2025) -
Supplementary Tables
par: Sushil Kumar (20371917)
Publié: (2025)